Environmental exposure and lung cancer among nonsmokers: An example of Taiwanese female lung cancer

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 21, Issue 1, 2003, Pages 1-28

  Cheng, Ya Wen ^a   Lee, Huei ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Environmental exposure; Lung cancer; Nonsmokers

Indexed keywords

AIR POLLUTION; DNA; GENES; HEALTH CARE; MUTAGENESIS; SMOKE;

CIGARETTE SMOKING;

TUMORS;

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; BENZO[A]PYRENE; CARCINOGEN; CIGARETTE SMOKE; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; DNA; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MESSENGER RNA; OIL; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; PROSTAGLANDIN E2; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

AIR POLLUTANT; AIR POLLUTION; ANIMAL MODEL; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ADDUCT; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; FEMALE; FUME; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; TAIWAN; TOBACCO; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AIR POLLUTION, INDOOR; COOKERY; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OILS; OXIDATIVE STRESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEX FACTORS; TAIWAN; TUMOR VIRUS INFECTIONS; WOMEN'S HEALTH;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; NICOTIANA TABACUM; PAPILLOMAVIRUS;

EID: 0037604850     PISSN: 10590501     EISSN: None     Source Type: Journal    
DOI: 10.1081/GNC-120021371     Document Type: Review

References (131)

1. Ger LP, Lious SH, Shen CY. Risk factors of lung cancer. J Formasa Med Assoc 1992; 91:S222-S231.
2. Annual Report of Tobacco. Alcohol Consumption Investigation in Taiwan Area. Taipei, Taiwan, Bureau of Tobacco and Alcohol Monopoly. Taiwan Provincial Government, 1993.
3. Travis ED, Lubin J, Ries L, Devesa S. United states lung carcinoma incidence trends. Am Cancer Soc 1996; 77:2464-2470.
4. Lubin JH, Blot WJ, Berrino F, Flamant R, Gillis CR, Kunze M, Schmahl D, Visco G. Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer 1984; 33:569-576.
5. Brownson RC, Alavanja MCR, Caporaso N, Simones EJ, Chang JC. Epidemiology and prevention of lung cancer in nonsmoker. Epidemiol Rev 1998; 20:218-235.
6. Brownson RC, Alvavanja MCR, Caporaso N, Simoes EJ, Chang JC. Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev 1998; 20:218-236.
7. Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, Zhang R, Fraumeni JF Jr. Lung cancer among Chinese women. Int J Epidemiol 1990; 19(suppl):S14-S23.
8. Wu-Williams AH, Dai XD, Blot W, Xu ZY, Sun XW, Xiao HP, Stone BJ, Yu SF, Feng YP, Ershow AG. Lung cancer among women in north-east China. Br J Cancer 1990; 62:982-987.
9. Ko YC, Lee CH, Chen MJ, Huang CC, Chang WY, Lin HJ, Wang HZ, Chang PY. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 1997; 26:24-31.
10. Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Henderson BE, Correa P. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995; 141:1023-1032.
11. Alavanja MC, Brownson RC, Boice JD Jr, Hock E. Preexisting lung diease and lung cancer among nonsmoking women. Am J Epidemiol 1992; 136:623-632.
12. Lewtas J, Walsh R, Williams R, Dobias L. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutation Res 1997; 378:51-63.
13. Phillips DH, Hewer A, Martin CN, Garner RC, King MM. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 1988; 336(6201):790-792.
14. Savela S, Hemminki K. DNA adducts in lymphocytes and granulocytes of smokers and non-smokers detected by 32P-postlabeling assay. Carcinogenesis 1991; 12:503-508.
15. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 1990; 46:569-575.
16. Poirier MC. DNA adducts as exposure biomarkers and indicator of cancer risk. Environ Health Perspect 1997; 105:907-912.
17. Kriek E, Rojas M, Alexandrov K, Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutation Res 1998; 400:215-231.
18. La DK, Swenberg JA. DNA adducts: biological markers of exposure and potential application to risk assessment. Mutation Res 1996; 365:129-146.
19. Perera F. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996; 88:496-509.
20. Cheng YW, Chen CY, Lin P, Chen CP, Huang KK, Lin TS, Wu MH, Lee H. DNA adduct level in lung tissue may be act as a risk biomarker of lung cancer. Eur J Cancer 2000; 36:1381-1388.
21. Schoket B, Phillip DH, Kostic S, Vincze I. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis 1998; 19:841-846.
22. Bartsch H, Rojas M, Alexandrov K, Camus AM, Castegnaro M, Malaveille C, Anttila S, Hirvonen K, Husgafvel-Pursiainen K, Hietanen E, Vainio H. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in human. Pharmacogenetics 1995; 5:S84-S90.
23. van Schooten FJ, Hillebrand MJ, van Leeuwen FE, Lutgerink JT, van Zandwijk N, Jansen HM, Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis 1990; 11(9):1677-1681.
24. Geneste O, Camus AM, Castegnaro M, Petruzzelli S, Macchiarini P, Angeletti CA, Giuntini C, Bartsch H. Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis 1991; 12(7):1301-1305.
25. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients Cancer Res 1994; 54(22):5801-5803.
26. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The molecular epidemiology of lung cancer. Critical Rev Toxicol 1997; 27(4):319-65.
27. 32P-Postlabeling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. Mutation Res 1997; 378:65-75.
28. Lee H, Su SY, Liu KS, Chou MC. Correlation between meteorological conditions and mutagenicity of airborne particulate samples in a tropical monsoon climate area from Kaohsiung city, Taiwan. Environ Mol Mutagen 1994; 23:200-207.
29. Kuo CY, Cheng YW, Chen CY, Lee H. Correlation between the amounts of polycyclic aromatic hydrocarbons and mutagenicity of airborne particulate samples from Taichung city, Taiwan. Environ Res 1998; 78:43-49.
30. Cherng SH, Lin P, Yang JL, Hsu SL, Lee H. Benzo[ghi]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by Ah receptor pathway. Toxicol Appl Pharm 2001; 170:63-68.
31. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996; 88:183-192.
32. Cheng YW, Hsieh LL, Lin P, Chen PL, Chen CY, Lin TS, Su JM, Lee H. Gender difference in DNA adduct levels among non-smoking lung cancer patients. Environ Mol Mutagen 2001; 37:304-310.
33. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 1995; 87:902-907.
34. Rojas M, Alexandrov K, Cascorbi I, Brockmoller J, Likhachev A, Pozharisski K, Bouvier G, Auburtin G, Mayer L, Kopp-Schneider A, Roots I, Bartsch H. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MsPI-GSTMI*0/*0 genotypes. Pharmacogenetics 1998; 8:109-118.
35. Tang DL, Rundle A, Warburton D, Santella RM, Tsai WY, Chiamprasert S, Hsu YZ, Perera FP. Association between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis 1998; 19:1949-1953.
36. Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999; 59(14):3317-3320.
37. Lin P, Wang SL, Wang HL, Chen KW, Lee HS, Tsai KJ, Chen CY, Lee H. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Brit J Cancer 2000; 82(4):852-857.
38. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg EF Jr. The role of oxidative stress in chemical carcinogenesis. Environ Health Persp 1998; 106:289-295.
39. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49:91-102.
40. Ho JC, Zeng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001; 61:8578-8585.
41. Mercurio F, Manning AM. NF-kB as a primary regulator of the stress response. Oncogene 1999; 18:6163-6171.
42. 2)-induced NF-kB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis 1998; 19:1583-1589.
43. Nakamura T, Sakamoto K. Reactive oxygen species up-regulates cyclooxygenase-2, p53, and Bax mRNA expression in bovine luteal cells. Biochem Biophys Res Commun 2001; 284:203-210.
44. Yan Z, Subbaramaiah K, Camille T, Zhang F, Tanabe T, McCaffrey TA, Dannenberg AJ, Weksler BB. Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells: evidence for the involvement of extracellular signal-regulated kinase and NF-kB. J Biol Chem 2000; 275:4949-4955.
45. Kelley DJ, Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Ramonetti JT, and Dannenberg AJ. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 1997; 18:795-799.
46. Sharma RA, Gescher A, Plastaras JP, Leuratti C, Singh R, Gallacher-Horley B, Offord E, Marnett LJ, Steward WP, Plummer SM. Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 2001; 22:1557-1560.
47. Lee JG, Madden MC, Reed W, Adler K, Devlin R. The use of the single cell gel electrophoresis assay in detecting DNA single strand breaks in lung cells in vitro. Toxicol Appl Pharmacol 1996; 141:195-204.
48. Yang SC, Jeng SN, Kang ZC, Lee H. Identification of benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions. Chem Res Toxicol 2000; 13:1046-1050.
49. Li S, Pan D, Wang G. Analysis of polycyclic aromatic hydrocarbons in cooking oil fumes. Arch Environ Health 1994; 49:119-122.
50. Chiang TA, Wu PF, Wang LF, Lee H, Lee CH, Ko YC. Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. Mutat Res 1997; 381:157-161.
51. Yasuhara A, Shibamoto T. Quantitative analysis of volatile aldehydes formed from various kinds of fish flesh during heat treatment. J Agri Food Chem 1995; 43:94-97.
52. Roman J, Gimenez A, Lluis JM, Gasso M, Rubio M, et al. Enhanced DNA binding and activation of transcription factors NF-kB and AP-1 by acetaldehyde in HepG2 cells. J Biol Chem 2000; 275:14684-14690.
53. Von Knethen A, Callsen D, Brune B. Superoxide attenuates macrophage apoptosis by NF-kB and AP-1 activation that promotes cyclooxygenase-2 expression. J Immuno 1999; 163:2858-2866.
54. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 2001; 276:12076-12083.
55. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for cancer chemotherapy. J Cancer Res Clin Oncol 2001; 127:411-417.
56. Rioux N, Castonguay A. The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kB. Carcinogenesis 2000; 21:1745-1751.
57. Kim HJ, Kim KW, Yu BP, Chung HY. The effect of age on cyclooxygenase-2 gene expression: NF-kappa B activation and IkappaBalpha degradation. Free Radic Biol Med 2000; 28:683-692.
58. Lin SY, Tsai SJ, Wang LH, Wu MF, Lee H. Protection of quercetin against cooking oil fumes-induced DNA damage in human lung adenocarcinoma CL-3 cells: the role of COX-2. Nutr Cancer, 2002; 44:95-101.
59. Marnett LJ, Basu AK, O'Hara SM, Weller PE, Rahaman AFMM, et al. Reaction of malondialdehyde with guanine nucleosides: formation of adducts containing oxaldrazabicyclononene residues in the base-pairing region. J Am Chem Soc 1998; 108:1348-1350.
60. Cherng SH, Huang KH, Yang SC, Wu TC, Yang JL, Lee H. Human 8-oxoguanosine DNA glycosylase 1 mRNA expression as an oxidative stress exposure biomarker of cooking oil fumes. J Toxicol Environ Health (Part A) 2002; 65:265-278.
61. Zienolddiny S, Ryberg D, Haugen A. Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines. Carcinogenesis 2000; 21:1521-1526.
62. Takabe W, Niki E, Uchida K, Yamada S, Satoh K, Noguchi N. Oxidative stress promotes the development of transformation involvement of a potent mutagenic lipid peroxidation product, acrolein. Carcinogenesis 2001; 22:935-941.
63. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387:147-163.
64. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984; 12:2137-2145.
65. Aburatani H, Hippo Y, Ishida T, Takashima R, Matsuba C, Kodama T, Takao M, Yasui A, Yamamoto K, Asano M, Fukasawa K, Yoshinari T, Inoue H, Ohtsuka E, Nishimura S. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res 1997; 57:2151-2156.
66. Arai K, Morishita K, Shinmura K, Kohno T, Kim SR, Nohmi T, Taniwaki M, Ohwada S, Yokota J. Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene 1997; 14:2857-2861.
67. Lu R, Nash HM, Verdine GL. A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer. Curr Biol 1997; 7:397-407.
68. Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1997; 94:8010-8015.
69. Roldan-Arjona T, Wei YF, Carter KC, Klungland A, Anselmino C, Wang RP, Augustus M, Lindahl T. Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase. Proc Natl Acad Sci USA 1997; 94:8016-8020.
70. Rosenquist TA, Zharkov DO, Grollman AP. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci USA 1997; 94:7429-7434.
71. Hollenbach S, Dhenant A, Eckert I, Radicella JP, Epe B. Overexpression of Ogg1 in mammalian cells: effects on induced and spontaneous oxidative DNA damage and mutagenesis. Carcinogenesis 1999; 20:1863-1868.
72. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H, Masumura KI, Nohmi T, Nishimura S, Noda T. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci USA 2000; 97:4156-4161.
73. Tsurudome Y, Hirano T, Yamato H, Tanaka I, Sagai M, Hirano H, Nagata N, Itoh H, Kasai H. Changes in levels of 8-hydroxyguanine in DNA, its repair and OGG1 mRNA in rat lungs after intratracheal administration of diesel exhaust particles. Carcinogenesis 1999; 20:1573-1576.
74. Zhong L, Goldberg MS, Parent ME, Hanley JA. Risk of developing lung cancer in relation to exposure to fumes from Chinese-style cooking. Scand J Work Environ Health 1999; 25:309-316.
75. Gao YT, Blot WJ, Zgeng W, Ershow AG, Hsu CW, Levin LI, Zhang R, Fraumeni JF Jr. Lung cancer among Chinese women. Int J Cancer 1987; 40:604-609.
76. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kB-responsive genes in cervical keratinocytes. J Virol 2001; 75:4283-4296.
77. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for cancer chemotherapy. J Cancer Res Clin Oncol 2001; 127:411-417.
78. Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93:705-716.
79. Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 2001; 276:20809-20812.
80. Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998; 58:1208-1216.
81. Huang M, Sharma S, Mao JT, Dubinett SM. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production J Immunol 1996; 157:5512-5520.
82. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253(5015):49-53.
83. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54(18):4855-4878.
84. Hussain SP, Harris CC. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998; 58(18):4023-4037.
85. Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res 2001; 61(17):6350-6355.
86. Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, Tang MS, Pfeifer GP. Targeting of lung cancer mutational hospots by polycyclin aromatic hydrocarbons. J Nat Cancer Int 2000; 92(10):803-811.
87. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998; 11(6):559-603.
88. Ronai ZA, Gradia S, Peterson LA, Hecht SS. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis 1993; 14(11):2419-2422.
89. Tiano HF, Wang RL, Hosokawa M, Crespi C, Tindall KR, Langenbach R. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells. Carcinogenesis 1994; 15(12):2859-2866.
90. Marchetti A, Pellegrini S, Sozzi G, Bertacca G, Gaeta P, Buttitta F, Carnicelli V, Griseri P, Chella A, Angeletti CA, Pierotti M, Bevilacqua G. Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus. Br J Cancer 1998; 78(1):73-78.
91. Takagi Y, Osada H, Kuroishi T, Mitsudomi T, Kondo M, Niimi T, Saji S, Gazdar AF, Takahashi T, Minna JD, Takahashi T. p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. Br J Cancer 1998; 77(10):1568-1572.
92. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev 1999; 8(4 Pt1):297-302.
93. Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Cancer Res 1998; 58(2):328-333.
94. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Comparision of mutations in the p53 and K-ras gene in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomar Prev 1999; 8:297-302.
95. Vahakangas KH, Bennett WP, Castren K, Welsh JA, Khan MA, Biomeke B, Alavanja MCR, Harris CC. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res 2001; 61:4350-4356.
96. Kasai H, Iida A, Yamaizumi Z, Nishimura S, Tanooka H. 5-Formyldeoxyuridine: a new type of DNA damage induced by ionizing radiation and its mutagenicity to Salmonella strain TA102. Mutat Res 1990; 243:249-253.
97. Douki T, Delatour T, Paganon F, Cadet J. Measurement of oxidative damage at pyrimidine bases in γ-irradiated DNA. Chem Res Toxicol 1996; 9:1145-1151.
98. Masaoka A, Terato H, Kobayashi M, Ohyama Y, Ide H. Oxidation of thymine to 5-formyluracil in DNA promotes misincorporation of dGMP and subsequent elongation of a mismatched primer terminus by DNA polymerase. J Biol Chem 2001; 276:16501-16510.
99. Zhang QM, Sugiyama H, Miyabe I, Matsuda S, Saito I, Yonei S. Replication of DNA templates containing 5-formyluracil, a major oxidative lesion of thymine in DNA. Nucleic Acids Res 1997; 25:3969-3973.
100. Achey PM, Wright CF. Inducible repair of thymine ring saturation damage in ΦX174 DNA. Radiat Res 1983; 93:609-612.
101. Chou MC, Lee H. Mutagenicity of airbone particles from four cities in Taiwan. Proc Natl Sci Counc B ROC 1990; 14:142-150.
102. Lee H, Su SY, Liu KS, Chou MC. Correlation between meteorological conditions and mutagenicity of airbone particulate samples in a tropical monsoon climate area from kaohsiung city, Taiwan. Environ Mol Mutagen 1994; 23:200-207.
103. Lee H, Lin TL, Shieh RL, Bian SS. Mutagenicity of airbone particulates from combustion of electric cables in a waste metal retrieval area. Mutation Res Lett 1994; 324:77-84.
104. Kuo CY, Cheng YW, Chen CY, Lee H. Correlation between the amounts of polycyclic aromatic hydrocarbons and mutagenicity of airbone particulate samples from Taichung city, Taiwan. Environ Res 1998; 78:43-49.
105. zur Hausen H. Papilloma viruses in human cancers. Proc Assoc Am Physicians 1999; 11:581-587.
106. Gorgoulis VG, Zacharatos P, Kotsinas A, Kyroudi A, Rassidakis AN, Ikonomopoulos JA, Barbatis C, Herrington CS, Kittas C. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999; 30:274-283.
107. Clavel CE, Nawrocki B, Bosseaux B, Poitevin G, Putaud IC, Mangeonjean CC, Monteau M, Birembaut PL. Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer 2000; 88:1347-1352.
108. Tsuhako K, Nakazato I, Hirayasu T, Sunakawa H, Iwamasa T. Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 1998; 51:741-749.
109. Soini Y, Nuorva K, Kamel D, Pollanen R, Vahakangas K, Lehto VP, Paakko P. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax 1996; 51:887-893.
110. Hirayasu T, Iwamasa T, Kamada Y, Koyanagi Y, Usuda H, Genka K. Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 1996; 49:810-817.
111. Hennig EM, Suo Z, Karlsen F, Hol R, Thoresen S, Nesland JM. HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III). Acta Oncol 1999; 38:639-647.
112. Storey A, Thomas M, Kalita A, Harwood C, Gardio D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393:229-234.
113. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, Su JM, Lee H. The association of human papillomavirus 16/18 infection with lung cancer among non-smoking Taiwanese women. Cancer Res 2001; 61:2799-2803.
114. Qingquan L, Ke H, Xianguang P, Zuoyan C, Jiong Y, Suping H. Detection of human papillomaviruses type 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J 1995; 108:610-614.
115. Padapodoulo K, Labropoulou V, Davaris P, Mavromara P, Tsimara-Papastamatiou H. Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch 1998; 433:49-54.
116. Nuorva K, Soini Y, Kamel D, Pollanen R, Bloigu R, Vahakangas K, Paakko. P. p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer 1995; 64:424-429.
117. Fong KM, Schonrock J, Frazer IM, Zimmerman PV, Smith PJ. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 1995; 75:2400-2401.
118. Shamanin V, Delius H, Villiers EM. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994; 75:1149-1156.
119. Tseng CJ, Pao CC, Lin JD, Soong YK, Hong JH, Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol 1999; 17:1391-1396.
120. Chiou HL, Wu MF, Liaw YC, ChengYW, Wong RH, Lee H. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 2003; 97:1558-1563.
121. Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W, Voravud N, Mutirangura A. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 2000; 6:1046-1051.
122. Lo YM, Chan LY, Chan AT, Leung SF, Lo KW, Zhangm J, Lee JC, Hjelm NM, Johnson PJ, Huang DP. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999; 59:5452-5455.
123. Liu VW, Tsang P, Yip A, Ng TY, Wong LC, Ngan HY. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol 2001; 82:269-272.
124. Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA, Sidransky D. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Marker Prev 2002; 11:3-6.
125. Miyagi J, Tsuhako K, Kinjo T, Iwamasa T, Hirayasu T. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 2000; 53:676-684.
126. Capone RB, Pai SI, Koch WM, Gillison ML, Danish HN, Westra WH, Daniel R, Shah KV, Sidransky D. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000; 6:4171-4175.
127. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355:2194-2198.
128. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355:2189-2193.
129. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002; 360:228-229.
130. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol 2000; 74:6622-6631.
131. Karin M, Gao Y, Greten FR, Li ZW. NF-kB in cancer: from innocent bystander to major culprit. Nature Rev Cancer 2002; 2:301-310.